Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000508111 | SCV000604416 | benign | not provided | 2017-09-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023435 | SCV003703260 | uncertain significance | not specified | 2021-11-09 | criteria provided, single submitter | clinical testing | The c.2513C>T (p.P838L) alteration is located in exon 24 (coding exon 23) of the MYO1A gene. This alteration results from a C to T substitution at nucleotide position 2513, causing the proline (P) at amino acid position 838 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |